<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ambruso DR</submitter><funding>Horizon Therapeutics</funding><funding>NIH/NCATS</funding><funding>Stacy True Memorial Trust Fund</funding><funding>Marranzino and Morgan families</funding><pagination>e0331657</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12416707</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(9)</volume><pubmed_abstract>&lt;h4>Trial registration&lt;/h4>ClinicalTrials.gov NCT03548818.</pubmed_abstract><journal>PloS one</journal><pubmed_title>Interferon-gamma 1b-induced gene expression alters neutrophil function in patients with chronic granulomatous disease.</pubmed_title><pmcid>PMC12416707</pmcid><funding_grant_id>UL1 TR002535</funding_grant_id><pubmed_authors>Sanford B</pubmed_authors><pubmed_authors>Tran AD</pubmed_authors><pubmed_authors>Briones NJ</pubmed_authors><pubmed_authors>Ambruso DR</pubmed_authors><pubmed_authors>Katz BZ</pubmed_authors><pubmed_authors>Jones KL</pubmed_authors><pubmed_authors>Johnston RB</pubmed_authors><pubmed_authors>Ellison M</pubmed_authors><pubmed_authors>Childs C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Interferon-gamma 1b-induced gene expression alters neutrophil function in patients with chronic granulomatous disease.</name><description>&lt;h4>Trial registration&lt;/h4>ClinicalTrials.gov NCT03548818.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-02T02:44:43.52Z</modification><creation>2026-04-13T03:12:50.781Z</creation></dates><accession>S-EPMC12416707</accession><cross_references><pubmed>40920799</pubmed><doi>10.1371/journal.pone.0331657</doi></cross_references></HashMap>